U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07758647) titled 'NO-Meal Announcement in Automated Insulin Delivery (Open-source and Commercial) Systems' on Aug. 06.
Brief Summary: Automated insulin delivery (AID) systems are the current gold standard for the management of type 1 diabetes (T1D), improving glycemic control, reducing hypoglycemia, and decreasing treatment burden. Although both commercial AID (C-AID) and open-source AID (OS-AID) systems have demonstrated significant clinical benefits, direct randomized comparisons between these systems remain scarce. Moreover, an important limitation of currently available AID systems is their reliance on user-initiated meal announcements and carboh...